April 13 (Reuters) - Teva Pharmaceutical (TEVA.TA), opens new tab must face a lawsuit claiming it used unlawful methods to block generic competition for its multiple sclerosis drug Copaxone, a New ...
A little less than a month after Pfizer's Upjohn unit and Mylan successfully merged to create generics business Viatris, the company is already looking at ways to slash costs. Newly minted Viatris ...
Get all latest & breaking news on Mylan Pharmaceuticals. Watch videos, top stories and articles on Mylan Pharmaceuticals at moneycontrol.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results